Accelerate Diagnostics
(OTC) AXDX
This security has been delisted. This page is retained for historical reference.
AXDX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAXDX Financials
Key Financial Metrics (TTM)
Gross Margin
23%
Operating Margin
-3%
Net Income Margin
-4%
Return on Equity
1%
Return on Capital
13%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.70M
Operating Income
-$35.31M
EBITDA
-$33.57M
Operating Cash Flow
-$24.19M
Capital Expenditure
-$509.00K
Free Cash Flow
-$24.70M
Cash & ST Invst.
$16.30M
Total Debt
$66.58M
Accelerate Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.82M
-6.1%
Gross Profit
$449.00K
-25.9%
Gross Margin
15.94%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
107
N/A
Net Income
-$9.59M
+26.2%
EBITDA
-$4.36M
+54.0%
Quarterly Fundamentals
Net Cash
-$50.28M
-93.4%
Accounts Receivable
$2.04M
-22.3%
Inventory
$2.85M
-13.8%
Long Term Debt
$49.44M
+33.9%
Short Term Debt
$17.14M
+649.7%
Return on Assets
-1.75%
N/A
Return on Invested Capital
13.35%
N/A
Free Cash Flow
-$5.07M
+35.6%
Operating Cash Flow
-$5.07M
+34.6%